Dianthus Therapeutics Inc. (DNTH) — Long-term Investment Intensity
Dianthus Therapeutics Inc. (DNTH) has a Long-term Investment Intensity of 9.1% as of March 2026. Long-term investments of $113.87 Million represent 9.1% of total assets of $1.25 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Dianthus Therapeutics Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Dianthus Therapeutics Inc. Long-term Investment Intensity (2024–2025)
This chart shows how Dianthus Therapeutics Inc.'s Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the intensity stands at 9.1%, reflecting long-term investments of $113.87 Million against total assets of $1.25 Billion USD. Explore DNTH operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Dianthus Therapeutics Inc. (2024–2025)
The table below presents the year-by-year Long-term Investment Intensity for Dianthus Therapeutics Inc. from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see DNTH company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 20.7% | $110.14 Million | $530.92 Million | ▼ -1.1 pp |
| 2024 | 21.9% | $81.73 Million | $374.01 Million | — |